12/09/2024 | Press release | Distributed by Public on 12/09/2024 16:00
Item 1.01 Entry into a Material Definitive Agreement.
On December 9, 2024, Cerus Corporation (the "Company") entered into the Second Amended and Restated Supply and Manufacturing Agreement ("2025 Agreement") with Porex Corporation ("Porex"), effective January 1, 2025 to extend the current term of the Amended and Restated Supply and Manufacturing Agreement until December 31, 2027. Under the terms of the 2025 Agreement, unit pricing for platelet wafers and plasma disks are set at certain amounts for the first twenty-four months, starting January 1, 2025, with volume based pricing after the first twenty-four months.
The foregoing description of the 2025 Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the 2025 Agreement. The Company intends to file a copy of the 2025 Agreement with the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2024.